NovaBridge Biosciences American Depositary Shares (NBP) Stock Price

NBPStock

$1.83−56.71%52W

Market Cap$212.22M

P/E—

PEG Ratio—

Div yield—

Beta1.56

NBP Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-55.31%

Price vs S&P 500 (4W)12.74%

VGM Score25.35

Book Value / Share (Quarterly)$0.75

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-73.83%

Cash Flow / Share (Quarterly)$-0.20

Price vs S&P 500 (YTD)-66.59%

Gross Margin (TTM)100.00%

Net Profit Margin (TTM)-439.76%

EPS (TTM)$-0.19

10-Day Avg Trading Volume0.30M

EPS Excl Extra (TTM)$-0.19

Revenue Growth (5Y)-12.47%

EPS (Annual)$-0.21

ROI (Annual)-20.03%

Gross Margin (Annual)100.00%

Net Profit Margin (5Y Avg)-1791.81%

Cash / Share (Quarterly)$0.72

ROA (Last FY)-17.76%

EBITD / Share (TTM)$-0.32

ROE (5Y Avg)-50.80%

Operating Margin (TTM)-416.50%

Cash Flow / Share (Annual)$-0.08

P/B Ratio1.09x

P/B Ratio (Quarterly)1.12x

Net Income / Employee (Annual)$-1,542,300

Net Interest Coverage (TTM)-6.29x

ROA (TTM)-19.41%

EPS Incl Extra (Annual)$-0.21

Current Ratio (Annual)8.09x

Quick Ratio (Quarterly)7.60x

3-Month Avg Trading Volume0.65M

52-Week Price Return-56.71%

Revenue / Employee (TTM)$0

P/S Ratio (Annual)7.93x

Asset Turnover (Annual)0.07x

52-Week High$6.79

Operating Margin (5Y Avg)-1670.60%

EPS Excl Extra (Annual)$-0.21

CapEx CAGR (5Y)-75.54%

26-Week Price Return-43.38%

Quick Ratio (Annual)8.06x

13-Week Price Return-1.60%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)7.64x

Enterprise Value$28.60M

Revenue / Share Growth (5Y)-18.84%

Asset Turnover (TTM)0.11x

Revenue / Employee (Annual)$0

Pretax Margin (Annual)-297.41%

Cash / Share (Annual)$0.79

3-Month Return Std Dev67.95%

Net Income / Employee (TTM)$-1,542,300

ROE (Last FY)-20.03%

Net Interest Coverage (Annual)-2.57x

EPS Basic Excl Extra (Annual)$-0.21

Receivables Turnover (TTM)-1.54x

EV / Free Cash Flow (TTM)0.85x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-0.19

Receivables Turnover (Annual)-1.54x

ROI (TTM)-20.91%

P/S Ratio (TTM)4.64x

Pretax Margin (5Y Avg)-1700.94%

Revenue / Share (Annual)$0.00

Price vs S&P 500 (52W)-75.26%

Year-to-Date Return-53.77%

5-Day Price Return-2.65%

EPS Normalized (Annual)$-0.21

ROA (5Y Avg)-37.54%

Net Profit Margin (Annual)-751.44%

Month-to-Date Return15.00%

EBITD / Share (Annual)$-0.43

Operating Margin (Annual)-260.52%

LT Debt / Equity (Annual)0.00x

ROI (5Y Avg)-50.69%

LT Debt / Equity (Quarterly)0.00x

EPS Basic Excl Extra (TTM)$-0.19

P/B Ratio (Annual)1.98x

Pretax Margin (TTM)-439.76%

Book Value / Share (Annual)$0.87

Price vs S&P 500 (13W)-3.56%

Beta1.56x

P/FCF (Annual)0.52x

Revenue / Share (TTM)$0.00

ROE (TTM)-20.91%

52-Week Low$1.46

gGradeF

mGradeD

vgmGradeD

NBP Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q4 2025	Apr 7, 2026	-$0.08	-$0.31	-287.50%(-$0.23)
Q3 2025	Dec 18, 2025	-$0.05	-$0.06	-20.00%(-$0.01)
Q2 2025	Aug 20, 2025	-$0.12	-$0.07	+41.67%(+$0.05)
Q1 2025	May 15, 2025	-$0.07	-$0.04	+38.46%(+$0.03)

NBP Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.22

Industry Peers — Pharmaceuticals(570)

Symbol	Value Score	Growth Score	Momentum Score	Price
NBPNovaBridge Biosciences American Depositary Shares	—	F	D	$1.83
LLYEli Lilly & Co.	D	B	C	$1153.58
JNJJohnson & Johnson	D	C	B	$266.27
ABBVABBVIE INC.	D	C	B	$255.65
MRKMerck & Co., Inc.	D	C	B	$147.59
NVSNovartis AG	C	C	C	$152.33
AZNAstraZeneca PLC	C	B	C	$162.75
NVONovo-Nordisk A/S	B	C	C	$45.38
ABTAbbott Laboratories	C	C	C	$110.32
PFEPfizer Inc.	C	D	B	$28.21
VRTXVertex Pharmaceuticals Inc	D	C	B	$537.93
BMYBristol-Myers Squibb Co.	B	B	B	$66.51
SNYSanofi American Depositary Shares (Each representing one-half of one ordinary share)	B	C	C	$44.49
GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares)	B	C	C	$50.34
REGNRegeneron Pharmaceuticals Inc	C	C	B	$792.83
TAKTakeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)	C	C	B	$18.00
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$35.86
ONCBeOne Medicines Ltd. American Depositary Shares	D	B	B	$355.93
RPRXRoyalty Pharma plc Class A Ordinary Shares	D	D	B	$61.15
ALNYAlnylam Pharmaceuticals, Inc.	D	A	D	$241.11
ZTSZOETIS INC.	C	C	D	$76.84
INSMInsmed, Inc.	F	A	C	$120.53
ROIVRoivant Sciences Ltd. Common Shares	D	F	B	$34.81
UTHRUnited Therapeutics Corp	C	C	B	$509.27
GMABGenmab A/S ADS	C	C	B	$33.05
VTRSViatris Inc. Common Stock	B	C	B	$16.32
ASNDAscendis Pharma A/S Ordinary Share	D	A	C	$262.64
JAZZJazz Pharmaceuticals, Inc.	B	C	B	$249.91
BBIOBridgeBio Pharma, Inc. Common Stock	F	A	B	$75.62
BMRNBioMarin Pharmaceuticals Inc	C	C	B	$65.31
MDGLMadrigal Pharmaceuticals, Inc. Common Stock	D	A	B	$526.32
CORTCorcept Therapeutics Inc.	F	C	B	$112.35
ELANElanco Animal Health Incorporated Common Stock	C	B	C	$23.88
ARWRArrowhead Research Corporation	D	A	B	$81.65
SMMTSummit Therapeutics Inc. Common Stock	F	—	D	$13.57
AXSMAxsome Therapeutics, Inc	D	B	C	$198.58
RDYDr. Reddy's Laboratories Limited American Depositary Shares	D	D	C	$12.16
IONSIonis Pharmaceuticals, Inc. Common Stock	D	D	C	$59.85
ABVXAbivax SA American Depositary Shares	—	—	C	$113.22
NUVLNuvalent, Inc. Class A Common Stock	—	—	B	$123.96
CYTKCytokinetics Inc.	F	D	C	$70.53
PRAXPraxis Precision Medicines, Inc. Common Stock	F	—	B	$338.00
PTGXProtagonist Therapeutics, Inc	F	B	B	$144.19
CRNXCrinetics Pharmaceuticals, Inc.	F	A	A	$84.98
TGTXTG Therapeutics, Inc.	D	B	B	$53.31
ALKSAlkermes Inc. plc	D	C	B	$46.87
SYRESpyre Therapeutics, Inc. Common Stock	—	—	B	$88.80
RYTMRhythm Pharmaceuticals, Inc. Common Stock	F	B	C	$105.52
TVTXTravere Therapeutics, Inc. Common Stock	F	B	A	$65.28
BLTEBelite Bio, Inc American Depositary Shares	—	—	C	$152.21
AMRXAmneal Pharmaceuticals, Inc. Class A Common Stock	C	C	B	$17.43

About NovaBridge Biosciences American Depositary Shares

NovaBridge Biosciences is a biotechnology company that identifies and develops pharmaceutical assets, combining clinical research with strategic business development to advance therapies toward commercialization. The company's pipeline includes Givastomig, VIS-101, Ragistomig, and Uliledlimab.